eISSN: 2299-0038
ISSN: 1643-8876
Menopause Review/Przegląd Menopauzalny
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank


Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
1/2013
vol. 12
 
Share:
Send email
Share:
abstract:
Review paper

Urinary tract infections in the menopausal period: optimal management

Paweł Milart
,
Ewa Woźniakowska
,
Sławomir Woźniak
,
Tomasz Palacz
,
Piotr Czuczwar
,
Wojciech Wrona
,
Piotr Szkodziak
,
Maciej Paszkowski
,
Tomasz Paszkowski

Przegląd Menopauzalny 2013; 1: 23–28
DOI: https://doi.org/10.5114/pm.2013.33417
Online publish date: 2013/03/05
View full text Get citation
 
PlumX metrics:
Urinary tract infections (UTI) are among the most common infectious diseases in women. They are observed particularly frequently in two groups of patients at different life stages, i.e., in young and sexually active women, and in postmenopausal women. This paper summarizes the current state of knowledge in the field of treatment of postmenopausal UTI.

Uncomplicated cystitis is a complex illness of multifactorial etiology, and various risk factors have to be considered during woman’s lifespan. In the postmenopause, well-known UTI risk factors are post-voiding residual urine, reduced urinary flow, urinary incontinence and pelvic floor dysfunction. Behavioral risk factors should also be considered. The drop of estrogens concentration typical of menopause may suggest the auxiliary management option in cases of UTI in this age group.

On the basis of recent literature review, the following conclusions seem to be justified:

• The great majority of uncomplicated urinary tract infections in women are caused by Escherichia coli, independent of the patient’s hormonal status.

• Fosfomycin, nitrofurantoin, ciprofloxacin and amox-clavulanate are most commonly recommended in empirical therapy of UTI in postmenopausal women. In many cases ultra-short and short protocols are preferable because of better compliance and tolerability.

• Systemic menopausal hormonal therapy does not provide effective prophylaxis of cystitis in menopausal women.

• Asymptomatic bacteriuria in postmenopausal women usually does not require any therapy.

• Adherence inhibition to urothelial cells and protection against biofilm formation are the key mechanisms of the antiuroseptic treatment especially with respect to the risk of recurrent UTIs.
keywords:

menopause, urinary tract infections, treatment, prophylaxis
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.